Clinical trial

Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI

NCT02921373

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2019-07-01

PhasePHASE1

Study timeline

Study start (estimated)2019-07-01Date precision: month

Registry last updated2024-07-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adverse Reaction to Diagnostic Agents and Kits Nosunresolved

Interventions

19F Cell Sense-labeled PBMCBIOLOGICAL

MRIDEVICE

Sponsors & collaborators

Gregory A. Dekabanlead sponsor

Western University, Canadacollaborator

Ontario Institute for Cancer Researchcollaborator

Mapped research locations

LondonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02921373 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.